||A Message from APP Pharmaceuticals, Inc.
American Pharmaceutical Partners, Inc. is a specialty drug company that
develops, manufactures and markets injectable pharmaceutical products, focusing
on the oncology, anti-infective and critical care markets. The company is one of
the largest producers of injectables, with more than 100 generic products in
more than 300 dosages and formulations. APP has acquired the exclusive North
American rights to manufacture and market a proprietary injectable oncology
product, currently in Phase III clinical trials for metastatic breast cancer and
being studied in a variety of other cancers. For more information, visit APP's
website at www.appdrugs.com .